The global glioblastoma multiforme treatment drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are fuelling the market growth include the growing prevalence of glioblastoma multiforme, increasing R&D, and favorable regulatory scenarios, which are anticipated to boost the market growth. The presence of a strong pipeline […]
